Novel immunotherapies for breast cancer: Focus on 2023 findings
Article in International Immunopharmacology (January 2024)
The most recent citing publications are shown below. View all 19 publications that cite this research output on Dimensions.
Prognostic Factors Effective on Survival in Unifocal Borderline Luminal B HER2-Negative and Triple-Negative Breast Cancers: a Cross-Sectional Study
Article in Indian Journal of Surgery (January 2022)
Can Estrogen Receptor, Progesterone Receptor, and Proliferative Index be Considered as Isolated Prognostic Factors of Overall Survival in Early luminal Breast Cancer?
Article in Open Access Macedonian Journal of Medical Sciences (November 2021)